Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Growth Strength UCITS ETF 13.06.2025 FTGS.LN IE000YZLMXT9 25,002.00 USD 511,315.59 20.451 ...
-
CrowdStrike Falcon for AWS Security Incident Response Strengthens Cyber Resilience for AWS Customers
AUSTIN, Texas--(BUSINESS WIRE)--CrowdStrike (NASDAQ: CRWD) today unveiled Falcon for AWS Security Incident Response at AWS re:Inforce 2025, a new program that provides AWS Security Incident Response customers with industry-leading cyber protection from the AI-native CrowdStrike Falcon® cybersecurity platform at preferred rates in the AWS Marketplace. This program delivers AI-powered incident response to help organizations respond to incidents faster, reduce risk, and strengthen their cloud secu...
-
Massachusetts Financial Services Company UK Regulatory Announcement: Form 8.3 - Unite Group plc - Amendment
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) Amendment – this form replaces the Rule 8.3 Disclosure published at 12:39PM on 13/06/25. Changes have been made to Sections 3(a). 1. KEY INFORMATION (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - February 13.06.2025 GFEB.LN IE000X8M8M80 650,002.00 USD 22,180,074.20 34.123 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - November 13.06.2025 GNOV LN IE000OJ31JQ4 1,750,002.00 USD 55,048,540.13 31.456 ...
-
Debuting at HITEC 2025, Agilysys Book With S.P.E.N.D. Lets Guests Reserve Package Entitlements With Zero Staff Involvement
ALPHARETTA, Ga. & INDIANAPOLIS--(BUSINESS WIRE)--Agilysys, Inc. (Nasdaq: AGYS), a leading global provider of hospitality software and services, today announced the launch of Agilysys Book with S.P.E.N.D. (Stay Package Entitlement New Dynamic), a technology breakthrough that increases ancillary revenue and guest personalization by simplifying how hotels sell and fulfill packages. HITEC attendees can see the solution in Booth #1611 in the Indiana Convention Center during the June 17 – 19 exhibiti...
-
OpenGate Capital Enters into Binding Agreement to Sell ScioTeq to Tikehau Capital
NEW YORK & PARIS--(BUSINESS WIRE)--OpenGate Capital (“OpenGate”), a global private equity firm, announced today that it has entered into a binding agreement for the sale of ScioTeq, a global leader in ruggedized displays for the aviation and defense industries, to the aerospace and defense fund of global alternative asset manager Tikehau Capital (ISIN code: FR0013230612; Ticker: TKO.FP). ScioTeq has a 40-year heritage of designing and manufacturing advanced visualization and computing solutions...
-
ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase of Groundbreaking UK Study Targeting High-Risk Patients
SAN DIEGO--(BUSINESS WIRE)--ClearNote Health announced initiation of patient enrollment for a landmark UK clinical study utilizing its Avantect Pancreatic Cancer Test....
-
Veristat Congratulates George Medicines on FDA Approval of WIDAPLIK™
SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--Veristat, a leading global clinical research organization (CRO) and consultancy, proudly congratulates George Medicines on the U.S. Food and Drug Administration (FDA) approval of WIDAPLIK™ (telmisartan, amlodipine and indapamide), a novel single pill combination treatment for hypertension in adults, including as initial treatment, to lower blood pressure. The approval of WIDAPLIK™ marks a significant milestone for George Medicines and the patients who will...
-
Semtech’s LoRaWAN® Innovation: Transformative IoT Insights
CAMARILLO, Calif.--(BUSINESS WIRE)--Semtech Corporation (Nasdaq: SMTC), a leading provider of high-performance semiconductor, Internet of Things (IoT) systems and cloud connectivity service solutions, will showcase its IoT leadership as Robert Comanescu, Semtech’s senior director and marketing head of IoT chips, joins the featured speakers at the upcoming 2025 Shanghai Internet of Things Exhibition on June 19, 2025. Comanescu will present during a key panel discussion hosted by the LoRa Allianc...